Zdrowie i gospodarka · 09/09/2010

FDA Releases Draft Guidance on Assessing Suicidality in Clinical Trials

The Food and Drug Administration (FDA) has made available a draft guidance document to help pharmaceutical companies evaluate the risk of suicidal thoughts or behaviors in patients taking new medications during clinical trials, a crucial step in ensuring the safety of these treatments.